Reduce proliferation of human bone marrow cells from acute myeloblastic leukemia with minimally differentiation by blocking lncRNA PVT1.
A GhadiriMohammad Jafar SharifiV MehrzadP BagheriPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
The findings declare that inhibition of PVT1 could be a new target in the treatment of AML-M0 and help to approach more to treatments with fewer side effects.
Keyphrases
- bone marrow
- acute myeloid leukemia
- endothelial cells
- liver failure
- mesenchymal stem cells
- signaling pathway
- respiratory failure
- long non coding rna
- induced pluripotent stem cells
- drug induced
- acute lymphoblastic leukemia
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- smoking cessation
- replacement therapy